The 50th Anniversary of the US Surgeon General's Report on Tobacco: What We've Accomplished and Where We Go From Here: A Presidential Advisory From the American Heart Association
Introduction
January 11, 2014, marks the 50th anniversary of a significant milestone in our nation's public health. It was on this date in 1964 that US Surgeon General, Dr. Luther Terry, courageously released the first Surgeon General's Report on Smoking and Health.1 This landmark report transformed the way Americans viewed tobacco, and was the beginning of a decades‐long decline in tobacco use. As we proudly mark this anniversary, it is important to not only reflect on the substantial progress that has been made since 1964 in reducing the toll of tobacco in America, but also the considerable work yet to be accomplished. Despite how far we have come, tobacco use remains the No. 1 cause of preventable death and disease in this country.2
Most Americans, including an increasing number of those reading this paper, are not old enough to have any recollection of just how ubiquitous tobacco use was in 1964 when nearly half of the population smoked.1 Smoking was pervasive in the workplace and at home, and cigarette advertising filled the airwaves. Notwithstanding the fact that for several decades prior to 1964 many doctors and public health organizations, including the American Heart Association (AHA), raised concerns that tobacco was the cause of serious health issues, those concerns were mostly ignored.3, 4In fact, in 1958, 44% of Americans believed smoking caused cancer, and only 33% believed it was linked with heart disease.5, 6
In 1961, the AHA joined a number of other major public health groups in writing to President John F. Kennedy asking for a national commission on smoking.1 As a result of this advocacy and increasing public health pressure to address this threat to the nation's health, a newly appointed Surgeon General Dr. Terry, established a commission in 1962 to study the existing literature on the health consequences of smoking. It was this commission that produced the now landmark 1964 report.1 Among other findings, the report stated that “Cigarette smoking is causally related to lung cancer in men; the magnitude of the effect of cigarette smoking far outweighs all other factors.” and “Male cigarette smokers have a higher death rate from coronary artery disease than nonsmoking males.”1 The report stated that similar impacts were likely among women, but because women historically smoked at lower rates than men, the population impact was not yet as clear.1
Reflecting on the release, Dr. Terry observed that the report “hit the country like a bombshell.”7 It was rated one of the top news stories of 1964, spurring landmark legislation that required warning labels on cigarettes and banned the advertising of tobacco products on television.8 By 1969, 70% of Americans believed smoking caused cancer, and 60% believed it caused heart disease.6
In the 2 decades that followed, the tobacco epidemic in this country seemed to be turning. Smoking declined from 42.4% in 1965 to 30.1% in 1985.9 As more research confirmed and expanded on the findings of the 1964 report,1, 2, 5, 9, 10, 11 it became common public knowledge that tobacco use was a major public health problem. But as the public was becoming increasingly aware of the dangers of tobacco,12 they were also being bombarded with aggressive tobacco industry marketing.12, 13 This, combined with the highly addictive nature of nicotine, resulted in millions of Americans continuing to smoke and remaining addicted for a lifetime.14 The public health challenge was clear—simply educating the public about the dangers of tobacco was not enough to dramatically reduce tobacco use. More aggressive action was necessary to accelerate the declines. In the late 1980s and early 1990s, the AHA and others began to significantly shift its attention and resources toward changing public policy and the environment where people lived and worked as an effective means to further reduce tobacco use. The smoke‐free movement and campaigns to raise tobacco taxes were born.
Communities started to pass laws restricting smoking inside public places.15, 16, 17 Compared with today, many of these early laws passed in the 1980s were remarkably weak; requiring separate smoking and nonsmoking sections. In 1990, San Luis Obispo, CA, became the first community in the world to pass a law prohibiting smoking in all indoor workplaces, including restaurants and bars.18, 19 California passed a statewide smoke‐free law in 1995. Bars were included in the law in 1998. Momentum toward more comprehensive legislation was building.
Policy targeting the cost of tobacco products as a means to discourage smoking began to take hold as well.20, 21 In 1988, California increased the tax on cigarettes by 25 cents per pack.22 More remarkably, a portion of the revenue raised from the tax was dedicated to a statewide tobacco prevention and cessation program, making California the first state to raise the tobacco tax for public health purposes, including the funding of tobacco control programs.22 Several other states followed suit in the early 1990s.23
Reinforcing the importance of the shift of emphasis to public policy and environmental change within the smoke‐free movement, research began to accumulate showing that these tax‐ and smoke‐free policy interventions were highly effective in reducing tobacco use.20, 21, 22, 24 For example, increasing the price of tobacco by 10% reduces overall cigarette consumption by ≈3% to 5%, lowers the number of young adult smokers by 3.5%, and cuts the number of children who smoke by 6% or 7%.25 Studies from around the world have now provided evidence for a reduction of heart attacks and hospitalizations after implementation of smoke‐free air laws.26, 27, 28
The culture and social norms about smoking also began to change. Smokers could no longer light up at work or while out to eat, so they smoked less. Children saw fewer smokers, changing their view that smoking was an acceptable behavior. Higher tobacco prices helped deter children from starting to smoke, and encouraged smokers to quit. Well‐funded state tobacco prevention programs helped build local and statewide infrastructures to mobilize communities, educate the public, and provide resources to help smokers quit.29
Another major milestone in the tobacco control movement occurred in 1998. Earlier in the decade, the states sued the major tobacco companies to recoup the cost of treating diseases caused by tobacco use.30, 31, 32 The result of these lawsuits was the Master Tobacco Settlement Agreement (MSA).33 Under the MSA, the states received millions of dollars from the tobacco companies.32 In hindsight, regrettably, states were not compelled to use a significant portion of the money for tobacco prevention and cessation programs, or any programs that targeted improving the nation's health.34 Although some states seized the historic opportunity to further impact tobacco use by dedicating the amounts necessary from the MSA financial windfall to fund comprehensive tobacco prevention efforts, many failed to do so.35 Further, funds that were dedicated to tobacco prevention in these early post‐MSA years inexorably eroded as states confronted the fiscal stresses of the economic downturns of the past decade.33 Only Alaska and North Dakota (if federal funding is taken into account) currently fund their tobacco prevention programs at levels recommended by the Centers for Disease Control and Prevention.33 Revenue from the MSA and tobacco taxes continues to flow toward other parts of state budgets despite the fact that state tobacco control program expenditures have been shown to be independently associated with overall reductions in smoking prevalence.36
In 2012, it is estimated that states collected $25.6 billion in revenue from the tobacco settlement and tobacco taxes, but spent only 1.8% of it—$456.7 million—on tobacco prevention and cessation.33 States are sacrificing long‐term health benefits and healthcare cost savings for short‐term budget fixes.37 If all states had funded their tobacco control programs at even the minimum levels recommended by the Centers for Disease Control and Prevention since the MSA, there could have been millions of fewer smokers just over a decade later.34, 35 The ongoing failure to allocate even a modest amount of money from the MSA and state tobacco taxes to cessation and prevention programs is one of the greatest failures in this nation's efforts to reduce tobacco addiction.34, 35
From 1995 to 2009, there was impressive progress in increasing tobacco taxes and passing smoke‐free laws. In 2000, the average state cigarette excise tax was 32.7 cents per pack.38 In 2009, it was $1.20 per pack.38 A total of 107 cigarette tax increases occurred in 45 states and the District of Columbia.38 Today, the average state cigarette tax is $1.53 per pack.23 Additionally, the federal tobacco excise tax was increased from 24 cents in 1998 to $1.01 in 2009.39 In 1995, almost none of the US population was covered by laws that, at a minimum, required smoke‐free restaurants and bars.38 Today, about 65% of the population is covered by these laws.11
The public health impact from these laws is hard to overstate. In 2013, Minnesota increased the state tobacco tax by $1.60 per pack.40 It is estimated that this price increase in this state alone will prevent >47 700 children from becoming smokers, spur >36 600 current adult smokers to quit, save >25 700 Minnesota residents from premature, smoking‐caused deaths, and save >$1.65 billion in future healthcare costs.40 Studies in communities across America showed that strong smoke‐free laws resulted in significant drops in hospital admissions due to heart attacks.16, 17, 41 Just 30 minutes of exposure to secondhand smoke increases the risk of a heart attack for a person already at‐risk.42 A study conducted by the University of California found that from its launch in 1989–2008, California's tobacco control program reduced healthcare costs by $134 billion, far more than the $2.4 billion spent on the program.43
The AHA joined the public health community in celebrating the passage and President Barack H. Obama's signature into law of the Family Smoking Prevention and Tobacco Control Act.44 Having advocated for by the AHA for over a decade, the law finally granted the US Food and Drug Administration (FDA) the authority to regulate tobacco products.45 Up to that point, tobacco products were completely unregulated.46 Now the law restricts cigarette and smokeless tobacco retail sales as well as tobacco product advertising and marketing to youth, prohibits “reduced harm” claims including “light,” “low,” or “mild,” without an FDA order to allow such marketing, and requires bigger, more prominent warning labels for cigarettes and smokeless tobacco products.47, 48 In 2012, attempts by the FDA to require graphic warning labels be prominently displayed on packages of cigarettes met legal opposition.49 As a result, these warning labels do not appear on cigarette packages. They do, however, remain available for clinicians to show to patients during counseling sessions about the benefits of cessation of smoking combustible tobacco (Figure 1). Evidence exists that such graphic images have an important deterrent effect on young individuals. In a survey, 53% of young adults said such warning labels would make them think about not smoking.50
Since the original report in 1964,1 the Surgeon General's office has issued 30 additional reports on tobacco.51 Each report has linked more diseases to tobacco use. In 2006, Surgeon General Richard Carmona appropriately stated that “The debate is over. The science is clear. Tobacco smoke pollution is a serious health hazard.”11 The 2006 report also stated that the only way to effectively eliminate the risk of secondhand smoke exposure is to completely remove it from indoor environments,11 providing further ammunition in the push towards smoke‐free laws covering the entire country.
As a country, we have made great strides since 1964 in reducing the toll of tobacco, but by no means is it time to declare victory. An unfortunate side effect of all the progress is a perception among the public and policy makers that the issue is resolved. Nothing could be further from the truth. Although the percentage of Americans smoking has dropped by more than half, the total number of smokers has declined only slightly because of population growth.52 In 1965, about 50 million Americans smoked. Today, about 44 million smoke.52 Unless there are dramatic reductions in tobacco use, tobacco will remain the No. 1 cause of preventable death and disease for many decades to come.2
And although the percentage of Americans who use tobacco has declined, tobacco use worldwide has skyrocketed. Currently, tobacco use causes 5 million deaths annually worldwide.53 If current trends continue, 8 million people will die from tobacco use each year by 2030.53 The tobacco industry also continues to aggressively market tobacco products and fight against effective tobacco control policies. Little cigars and cigarillos, which are not currently regulated by the FDA and are sold in flavors like chocolate, grape, strawberry, and “Da Bomb Blueberry,” are gaining in popularity among youth.54 In 2012, tobacco companies spent an estimated $47 million to successfully defeat a ballot initiative in California that would have raised the tobacco tax by $1.00.55
The tobacco industry is also pushing so‐called “reduced harm” or “modified harm” tobacco products. Products like chewing tobacco, snus, and electronic cigarettes (e‐cigarettes) are marketed by the industry as safe alternatives to smoking. The industry is also lobbying for federal and state laws and resolutions directing health authorities to promote these products.56, 57, 58 Research is very clear that some of these products, like chewing tobacco and snus, are still dangerous and can cause cancer and other diseases.59, 60, 61, 62 There is also significant concern that smokers will use these products only when they are unable to smoke, but will continue smoking when able.63, 64 This is known as dual‐use.
E‐cigarettes present a unique challenge (Figure 2). They deliver a nicotine vapor without the combustion products that are responsible for most of smoking's damaging effects. They use vaporization at a lower operating temperature (5% to 10% of the temperature of a lit cigarette) to deliver nicotine and other constituents in a way that mimics smoking behavior.65 The impact of these products on cessation, dual use, youth initiation, social norms, and public health needs further elucidation.
This is a quickly evolving issue. It will be important for the public health community to determine which public policies that apply to combustible cigarettes also should apply to e‐cigarettes. E‐cigarette companies, which include the major tobacco companies, are aggressively marketing these products as a way for smokers to get their nicotine hit in places that restrict smoking.66, 67, 68 This has the potential to create enforcement problems with existing smoke‐free laws, as it would require business owners to determine if a customer is using an e‐cigarette or a combustible cigarette. E‐cigarettes are also being indirectly marketed as cessation aids, although the FDA has not approved them to be used in this manner.63, 69, 70
The use of e‐cigarettes among youth has grown dramatically in recent years. According to the Centers for Disease Control and Prevention, e‐cigarette use among high school students more than doubled from 4.7% in 2011 to 10% in 2012 (where 1.78 million students ever used e‐cigarettes).71 Among youth who use e‐cigarettes, 75% smoke conventional cigarettes as well.70 Until more research is available regarding the potential health harms of e‐cigarette use, as well as the risk of e‐cigarettes serving as a gateway for youth to become addicted to tobacco, these products should be carefully regulated by the FDA.
Tobacco use is one of the most extensively researched areas in public health; however, much more research is still needed. One of the areas needing more research is determining behavior modification techniques, in addition to pharmacologic approaches, that are most effective in helping tobacco users quit. When combined with cessation counseling and behavior modification techniques, the effectiveness of pharmacologic approaches improves significantly.72, 73
There has been much progress since the Surgeon General's first report on tobacco,1 but tobacco use continues to be a public health epidemic that requires urgent attention. It remains a major correctable and avoidable cause of cardiovascular disease.74 We know what needs to be done. Unfortunately, progress in passing tobacco taxes, smoke‐free laws and allocating funds for tobacco prevention and cessation has stalled in recent years. Only 3 states have raised their tobacco tax since 2011. The average state tax rate of $1.53 per pack does not cover the per‐pack healthcare and lost productivity costs to the states, which are estimated to be $10.47 per pack.75 Moreover, there are large disparities across the country between the states with high tobacco tax rates and those with low tax rates (Figure 3).23 The states with lower tax rates often have much higher tobacco use rates.23
Although local communities across the country continue to pass smoke‐free laws,76 only 3 states have passed strong laws in the past 3 years.73 Many Americans, particularly in the Southeast, are still not protected by smoke‐free laws.73 And total funding for tobacco prevention remains far below the levels recommended by the Centers for Disease Control and Prevention.77 It is time for policy makers to act.
The AHA remains highly committed to eliminating the toll of tobacco in America. As we mark the 50th anniversary of the first Surgeon General's Report on Tobacco and Health, let us all renew our commitment to ensuring that future generations live free from tobacco addiction.
Acknowledgment
The authors would like to thank Colby Tiner who did extensive work preparing this paper for publication and researching appropriate citations.
Footnotes
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.
This document was approved by the American Heart Association Science Advisory and Coordinating Committee on December 13, 2013. A copy of the document is available at http://my.americanheart.org/statements by selecting either the “By Topic” link or the “By Publication Date” link.
The American Heart Association requests that this document be cited as follows: Antman E, Arnett D, Jessup M, Sherwin C. The 50th anniversary of the US Surgeon General's report on tobacco: what we've accomplished and where we go from here: a presidential advisory from the American Heart Association. J Am Heart Assoc. 2014;3:e000740 doi: https://doi.org/10.1161/JAHA.113.000740.
Expert peer review of AHA Scientific Statements is conducted by the AHA Office of Science Operations. For more on AHA statements and guidelines development, visit http://my.americanheart.org/statements and select the “Policies and Development” link.
References
1.
US Department of Health and Human Services . Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington, DC: US Department of Health and Human Services; 1964. Available at: http://profiles.nlm.nih.gov/NN/B/B/M/Q/_/nnbbmq.pdf. Accessed December 20, 2013.
2.
Centers for Disease Control and Prevention . Smoking and Tobacco Use: Fast Facts. Washington, DC: Centers for Disease Control and Prevention; 2013. Available at: http://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/. Accessed December 20, 2013.
3.
Buechley RW, Drake RM, Breslow L. Relationship of amount of cigarette smoking to coronary heart disease mortality rates in men. Circulation. 1958;18:1085–1090.
4.
American Heart Association . Cigarette smoking and cardiovascular diseases. Circulation. 1960;22:160–166.
5.
US Department of Health and Human Services . Reducing Tobacco Use: A Report of the Surgeon General. Washington, DC: US Department of Health and Human Services; 2000.
6.
Gallup GH. The Gallup Poll: Public Opinion 1935–71. Vol 2. New York, NY: RandomHouse; 1972. Available at: http://legacy.library.ucsf.edu/tid/qpb42c00. Accessed December 20, 2013.
7.
US Department of Health and Human Services . The Reports of the Surgeon General: The 1964 Report on Smoking and Health: Brief History. Washington, DC: US Department of Health and Human Services; 2013. Available at: http://profiles.nlm.nih.gov/ps/retrieve/Narrative/NN/p-nid/60. Accessed December 20, 2013.
8.
Federal Cigarette Labeling and Advertising Act of 1965. Pub. L. No. 89–92, 15 USC 1331 et seq. (July 27, 1965, as amended by Pub. L. No. 91–222, 84 Stat. 87, Apr. 1, 1970 and Pub. L. No. 98–474, 98 Stat. 2204, October 12, 1984).
9.
US Department of Health and Human Services . Reducing the Health Consequences of Smoking: 25 Years of Progress: A Report of the Surgeon General, 1989. Washington, DC: US Department of Health and Human Services; 1989. Publication CDC 89‐8411.
10.
Enstrom JE, Kabat GC, Smith D. Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960–98. BMJ. 2003;326:1057.
11.
US Department of Health and Human Services . The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Washington, DC: US Department of Health and Human Services; 2006.
12.
Chaloupka FJ, Cummings KM, Morley CP, Horan JK. Tax, price and cigarette smoking: evidence from the tobacco documents and implications for tobacco company marketing strategies. Tob Control. 2002;11(suppl 1):i62–i72.
13.
Katz MH. Banning tobacco sales in pharmacies: the right prescription. JAMA. 2008;300:1451–1453.
14.
Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd‐Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PWF, Woo YJ; on behalf of the American Heart Association Advocacy Coordinating Committee, Stroke Council, Council on Cardiovascular Radiology and Intervention, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular Nursing, Council on the Kidney in Cardiovascular Disease, Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research . Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933–944.
15.
Meyers DG, Neuberger JS. Cardiovascular effect of bans on smoking in public places. Am J Cardiol. 2008;102:1421–1424.
16.
Mackay DF, Irfan MO, Haw S, Pell JP. Meta‐analysis of the effect of comprehensive smoke‐free legislation on acute coronary events. Heart. 2010;96:1525–1530.
17.
Centers for Disease Control and Prevention . Reduced hospitalizations for acute myocardial infarction after implementation of a smoke‐free ordinance—City of Pueblo, Colorado, 2002–2006. MMWR Morb Mortal Wkly Rep. 2009;57:1373–1377.
18.
Glantz SA, Smith LR. The effect of ordinances requiring smoke‐free restaurants on restaurant sales. Am J Public Health. 1994;84:1081–1085.
19.
Glantz SA, Smith LR. The effect of ordinances requiring smoke‐free restaurants and bars on revenues: a follow‐up. Am J Public Health. 1997;87:1687–1693.
20.
Wilson LM, Avila Tang E, Chander G, Hutton HE, Odelola OA, Elf JL, Heckman‐Stoddard BM, Bass EB, Little EA, Haberl EB, Apelberg BJ. Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review. J Environ Public Health. 2012;2012:961724.
21.
Community Preventive Services Task Force (the Community Guide) . Reducing Tobacco Use and Secondhand Smoke Exposure: Increasing the Unit Price of Tobacco Products. Task Force Finding and Rationale Statement. 2012. Available at: http://www.thecommunityguide.org/tobacco/RRincreasingunitprice.html. Accessed December 20, 2013.
22.
Flewelling RL, Kenney E, Elder JP, Pierce J, Johnson M, Bal DG. First‐year impact of the 1989 California cigarette tax increase on cigarette consumption. Am J Public Health. 1992;82:867–869.
23.
Campaign for Tobacco‐Free Kids . State Cigarette Excise Tax Rates & Rankings. 2013. Available at: http://www.tobaccofreekids.org/research/factsheets/pdf/0097.pdf. Accessed December 20, 2013.
24.
Sung HY, Hu TW, Ong M, Keeler TE, Sheu ML. A major state tobacco tax increase, the master settlement agreement, and cigarette consumption: the California experience. Am J Public Health. 2005;95:1030–1035.
25.
Chaloupka FJ. Macro‐social influences: the effects of prices and tobacco‐control policies on the demand for tobacco products. Nicotine Tob Res. 1999;1(suppl 1):S105–S109.
26.
Secondhand smoke exposure and cardiovascular effects: making sense of the evidence. Committee on Secondhand Smoke Exposure and Acute Coronary Events. Washington, DC: Board on Population Health and Public Health Practice. Institute of Medicine; October 15, 2009.
27.
US Department of Health and Human Services . How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking‐Attributable Disease: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
28.
Dinno A, Glantz S. Clean indoor air laws immediately reduce heart attacks. Prev Med. 2007;45:9–11.
29.
Shelton DM, Alciati MH, Chang MM, Fishman JA, Fues LA, Michaels J, Bazile RJ, Bridgers JC Jr, Rosenthal JL, Kutty L, Eriksen MP. State laws on tobacco control—United States, 1995. MMWR CDC Surveill Summ. 1995;44:1–28.
30.
Janofsky M. Mississippi seeks damages from tobacco companies. New York Times. May 24, 1994. Available at: http://www.nytimes.com/1994/05/24/us/mississippi-seeks-damages-from-tobacco-companies.html. Accessed December 20, 2013.
31.
Wolfson A. West Virginia takes on tobacco over health costs. Cour J. September 22, 1994.
32.
Goldstein A. Maryland to sue makers of cigarettes; effect of smoking on Medicaid at issue. Washington Post. November 17, 1995.
33.
National Association of Attorneys General . Master settlement agreement. 1998. Available at: http://www.naag.org/tobac/cigmsa.rtf. Accessed December 20, 2013.
34.
Pierce JP, Gilpin EA, Emery SL, White MM, Rosbrook B, Berry CC, Farkas AJ. Has the California tobacco control program reduced smoking? JAMA. 1998;280:893–899.
35.
Campaign for Tobacco‐Free Kids . A broken promise to our children: the 1998 state tobacco settlement 14 years later. 2012. Available at: http://www.tobaccofreekids.org/what_we_do/state_local/tobacco_settlement/. Accessed December 20, 2013.
36.
Farrelly MC, Pechacek TF, Thomas KY, Nelson D. The impact of tobacco control programs on adult smoking. Am J Public Health. 2008;98:304–309.
37.
Campaign for Tobacco‐Free Kids . New report: states slash tobacco prevention funding by 36%, spend less than 2 cents of every tobacco dollar to fight tobacco use. 2011. Available at: http://www.tobaccofreekids.org/press_releases/post/2011_11_30_state_report. Accessed December 20, 2013.
38.
Centers for Disease Control and Prevention . Federal and state cigarette excise taxes—United States, 1995–2009. MMWR Morb Mortal Wkly Rep. 2009;58:524–527.
39.
Campaign for Tobacco‐Free Kids . Increasing the federal tobacco tax reduces tobacco use (and the tobacco companies know it). 2013. Available at: http://www.tobaccofreekids.org/research/factsheets/pdf/0021.pdf. Accessed November 13, 2013.
40.
Campaign for Tobacco‐Free Kids . Minnesota tax increase is big win for kids and health. 2013. Available at: http://www.tobaccofreekids.org/press_releases/post/2013_05_21_minnesota. Accessed November 13, 2013.
41.
Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smoke‐free laws and individual risk attributable to secondhand smoke. Circulation. 2009;120:1373–1379.
42.
Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997;315:973–980.
43.
Lightwood J, Glantz SA. The effect of the California tobacco control program on smoking prevalence, cigarette consumption, and healthcare costs: 1989–2008. PLoS One. 2013;8(2):e47145.
44.
The American Heart Association . Statement by American Heart Association CEO Nancy Brown on Enactment of the Family Smoking Prevention and Tobacco Control Act. June 22, 2009. Available at: http://newsroom.heart.org/news/759. Accessed December 20, 2013.
45.
Family Smoking Prevention and Tobacco Control Act, Public Law No. 111‐31, §901, 123 Stat. 1776, (June 22, 2009). Available at: http://www.gpo.gov/fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf. Accessed December 20, 2013.
46.
Deyton LR. FDA tobacco product regulations: a powerful tool for tobacco control. Public Health Rep. 2011;126:167–169.
47.
Family Smoking Prevention and Tobacco Control Act, Public Law No. 111‐31, §911, 123 Stat. 1776, (June 22, 2009). Available at: http://www.gpo.gov/fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf. Accessed December 20, 2013.
48.
Campaign for Tobacco‐Free Kids . FDA regulation of tobacco products: a common sense law to protect kids and save lives. 2010. Available at: https://www.tobaccofreekids.org/research/factsheets/pdf/0352.pdf. Accessed November 13, 2013.
49.
Fellerbaum M. APNewsBreak: US to revise cigarette warning labels. Assoc Press. March 19, 2013. Available at: http://news.yahoo.com/apnewsbreak-us-revise-cigarette-warning-190137686.html. Accessed December 20, 2013.
50.
Villanti AC, Cantrell J, Pearson JL, Vallone DM, Rath JM. Perceptions and perceived impact of graphic cigarette health warning labels on smoking behavior among U.S. young adults. Nicotine Tob Res. 2013; Nov 8. [Epub ahead of print].
51.
US Department of Health and Human Services . Reports of the Surgeon General, US Public Health Service. Washington, DC: US Department of Health and Human Services; 2013. Available at: http://www.surgeongeneral.gov/library/reports/. Accessed December 20, 2013.
52.
MD Anderson Cancer Center . Just the Facts: Smoking and Tobacco Use. Houston, TX: MD Anderson Cancer Center; 2013. Available at: http://www.mdanderson.org/patient-and-cancer-information/cancer-information/community-services/brochures/pdfs/smoking-2013-r1.pdf. Accessed November 13, 2013.
53.
World Health Organization . WHO Report on the Global Tobacco Epidemic, 2013: Enforcing Bans on Tobacco Advertising, Promotion and Sponsorship: Executive Summary. Geneva, Switzerland: World Health Organization; 2013. Available at: https://extranet.who.int/iris/restricted/bitstream/10665/85381/1/WHO_NMH_PND_13.2_eng.pdf. Accessed December 20, 2013.
54.
King BA, Tynan MA, Dube SR, Arrazola R. Flavored‐little‐cigar and flavored cigarette use among U.S. middle and high school students. J Adolesc Health. 2013; Oct 22. [Epub ahead of print].
55.
Campaign for Tobacco‐Free Kids . Spending on tobacco prevention: California. 2012. Available at: http://www.tobaccofreekids.org/what_we_do/state_local/tobacco_settlement/california. Accessed November 13, 2013.
56.
Bogardus K, Hatlem J. E‐cigarette makers worry new regulations will snuff out emerging business. The Hill. November 2, 2013. http://thehill.com/blogs/regwatch/pending-regs/189030-e-cigarette-makers-ramp-up-lobbying-efforts. Accessed December 20, 2013.
57.
Daniels C. Rise of e‐cigarettes sparks tobacco industry plans. PRWeek. October 28, 2013. Available at: http://www.prweekus.com/rise-of-e-cigarettes-sparks-tobacco-industry-plans/article/317734/. Accessed December 20, 2013.
58.
Brinkerhoff N, Biederman D. $2‐Billion e‐cigarette industry unleashes lobbying blitz to limit taxes and regulation. AllGov.com. October 10, 2013. Available at: http://www.allgov.com/news/top-stories/2-billion-dollar-e-cigarette-industry-unleashes-lobbying-blitz-to-limit-taxes-and-regulation-131010?news=851357. Accessed December 20, 2013.
59.
Cameron JM, Howell DN, White JR, Andrenyak DM, Layton ME, Roll JM. Variable and potentially fatal amounts of nicotine in e‐cigarette nicotine solutions. Tob Control. 2014;23:77–78.
60.
Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska‐Czapla M, Rosik‐Dulewska C, Havel C, Jacob P III, Benowitz N. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2013; Mar 6. [Epub ahead of print]
61.
Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One. 2013;8(3):e57987.
62.
Series R. Electronic cigarettes—an overview. Tob Prev Tob Control. 2013;19:1–39.
63.
Lee S, Grana RA, Glantz SA. Electronic cigarette use among Korean adolescents: A cross‐sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. J Adolesc Health. 2013; Nov 22. [Epub ahead of print].
64.
Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as smoking‐cessation tool: results from an online survey. Am J Prev Med. 2011;40:472–475.
65.
Caponnetto P, Campagna D, Papale G, Russo C, Polosa R. The emerging phenomenon of electronic cigarettes. Expert Rev Respir Med. 2012;6:63–74.
66.
McKee M. E‐cigarettes and the marketing push that surprised everyone. BMJ. 2013;347:f5780.
67.
Yamin CK, Bitton A, Bates DW. E‐cigarettes: a rapidly growing Internet phenomenon. Ann Intern Med. 2010;153:607–609.
68.
Paek HJ, Kim S, Hove T, Huh JY. Reduced harm or another gateway to smoking? Source, message, and information characteristics of e‐cigarette videos on YouTube. J Health Commun. 2013; Oct 11. [Epub ahead of print]
69.
Odum LE, O'Dell KA, Schepers JS. Electronic cigarettes: do they have a role in smoking cessation? J Pharm Pract. 2012;25:611–614.
70.
Benowitz NL, Goniewicz ML. The regulatory challenge of electronic cigarettes. JAMA. 2013;310:685–686.
71.
Arrazola RA, Kuiper NM, Dube SR. Patterns of current use of tobacco products among U.S. high school students for 2000–2012—findings from the National Youth Tobacco Survey. J Adolesc Health. 2013; Sep 25. [Epub ahead of print].
72.
Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K. The effectiveness and cost effectiveness of telephone counseling and the nicotine patch in a state tobacco quitline. Tob Control. 2007;16(suppl 1):i53–i59.
73.
Fellows JL, Bush T, McAfee T, Dickerson J. Cost effectiveness of the Oregon quitline “free patch initiative”. Tob Control. 2007;16(suppl 1):i47–i52.
74.
American Heart Association . Reducing the burden of tobacco: establishing sustainable funding for tobacco cessation and prevention programs. 2013. Available at: http://www.heart.org/idc/groups/heart-public/@wcm/@adv/documents/downloadable/ucm_321035.pdf. Accessed December 20, 2013.
75.
American Lung Association . State of tobacco control—2013. 2013. http://www.stateoftobaccocontrol.org/sotc-2013-report.pdf. Accessed November 13, 2013.
76.
American Non‐Smokers’ Rights Foundation . Municipalities with Local 100% Smokefree Laws. 2013. Available at: http://www.no-smoke.org/pdf/100ordlisttabs.pdf. Accessed December 20, 2013.
77.
Campaign for Tobacco‐Free Kids . FY2013 Rankings of Funding for State Tobacco Prevention Programs. 2013. Available at: http://www.tobaccofreekids.org/content/what_we_do/state_local_issues/settlement/FY2013/3.%20FY2013%20Rankings%20of%20Funding%20for%20State%20Tobacco%20Prevention%20Programs%2011-19-12.pdf. Accessed December 20, 2013.
Information & Authors
Information
Published In
Copyright
© 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
History
Published online: 8 January 2014
Published in print: 27 January 2014
Keywords
Subjects
Authors
Disclosures
Writing Group Member | Employment | Research Grant | Other Research Support | Speakers’ Bureau/Honoraria | Expert Witness | Ownership Interest | Consultant/Advisory Board | Other |
---|---|---|---|---|---|---|---|---|
Elliott Antman | Brigham and Women's Hospital, Boston | None | None | None | None | None | None | None |
Donna Arnett | University of Alabama Birmingham | None | None | None | None | None | None | None |
Mariell Jessup | University of Pennsylvania | None | None | None | None | None | None | None |
Chris Sherwin | American Heart Association | None | None | None | None | None | None | None |
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (1) the person receives $10 000 or more during any 12‐month period, or 5% or more of the person's gross income; or (2) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association, Circulation, 149, 8, (e347-e913), (2024)./doi/10.1161/CIR.0000000000001209
- Collective action lessons for the energy transition: learning from social movements of the past, Sustainability Science, 19, 3, (847-863), (2024).https://doi.org/10.1007/s11625-023-01455-5
- Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association, Circulation, 147, 8, (e93-e621), (2023)./doi/10.1161/CIR.0000000000001123
- Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association, Circulation, 145, 8, (e153-e639), (2022)./doi/10.1161/CIR.0000000000001052
- Endogenous CO Production in Sickness and in Health , Carbon Monoxide in Drug Discovery, (1-26), (2022).https://doi.org/10.1002/9781119783435.ch1
- Heart Disease and Stroke Statistics—2021 Update, Circulation, 143, 8, (e254-e743), (2021)./doi/10.1161/CIR.0000000000000950
- A Qualitative Study to Explore Perception of Impacts of Preemption of Tobacco Regulation on Counties in Appalachian Tennessee, International Journal of Environmental Research and Public Health, 17, 9, (3230), (2020).https://doi.org/10.3390/ijerph17093230
- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association, Circulation, 141, 9, (e139-e596), (2020)./doi/10.1161/CIR.0000000000000757
- Turning Experience into Action: This Is Our Lane, Current Trauma Reports, 6, 1, (5-9), (2020).https://doi.org/10.1007/s40719-020-00187-6
- Assessment of Incorporation of Lessons From Tobacco Control in City and County Laws Regulating Legal Marijuana in California, JAMA Network Open, 3, 6, (e208393), (2020).https://doi.org/10.1001/jamanetworkopen.2020.8393
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.